NM_001099404.2:c.1140+98G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001099404.2(SCN5A):​c.1140+98G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.803 in 1,409,404 control chromosomes in the GnomAD database, including 455,429 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.80 ( 49377 hom., cov: 34)
Exomes 𝑓: 0.80 ( 406052 hom. )

Consequence

SCN5A
NM_001099404.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.102

Publications

16 publications found
Variant links:
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]
SCN5A Gene-Disease associations (from GenCC):
  • Brugada syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Brugada syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1E
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • sick sinus syndrome 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • progressive familial heart block, type 1A
    Inheritance: SD, AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
  • atrial standstill
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial sick sinus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • paroxysmal familial ventricular fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive familial heart block
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 3-38606571-C-T is Benign according to our data. Variant chr3-38606571-C-T is described in ClinVar as Benign. ClinVar VariationId is 1292202.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.961 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN5ANM_001099404.2 linkc.1140+98G>A intron_variant Intron 9 of 27 ENST00000413689.6 NP_001092874.1 Q14524H9KVD2
SCN5ANM_000335.5 linkc.1140+98G>A intron_variant Intron 9 of 27 ENST00000423572.7 NP_000326.2 Q14524-2Q86V90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN5AENST00000413689.6 linkc.1140+98G>A intron_variant Intron 9 of 27 5 NM_001099404.2 ENSP00000410257.1 H9KVD2
SCN5AENST00000423572.7 linkc.1140+98G>A intron_variant Intron 9 of 27 1 NM_000335.5 ENSP00000398266.2 Q14524-2

Frequencies

GnomAD3 genomes
AF:
0.804
AC:
122321
AN:
152094
Hom.:
49327
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.786
Gnomad AMI
AF:
0.766
Gnomad AMR
AF:
0.813
Gnomad ASJ
AF:
0.800
Gnomad EAS
AF:
0.984
Gnomad SAS
AF:
0.868
Gnomad FIN
AF:
0.812
Gnomad MID
AF:
0.816
Gnomad NFE
AF:
0.794
Gnomad OTH
AF:
0.811
GnomAD4 exome
AF:
0.803
AC:
1008948
AN:
1257192
Hom.:
406052
AF XY:
0.804
AC XY:
498733
AN XY:
620146
show subpopulations
African (AFR)
AF:
0.779
AC:
22361
AN:
28706
American (AMR)
AF:
0.839
AC:
27574
AN:
32846
Ashkenazi Jewish (ASJ)
AF:
0.798
AC:
18127
AN:
22714
East Asian (EAS)
AF:
0.972
AC:
33836
AN:
34806
South Asian (SAS)
AF:
0.865
AC:
62616
AN:
72394
European-Finnish (FIN)
AF:
0.808
AC:
32160
AN:
39796
Middle Eastern (MID)
AF:
0.816
AC:
3674
AN:
4504
European-Non Finnish (NFE)
AF:
0.791
AC:
765744
AN:
968376
Other (OTH)
AF:
0.808
AC:
42856
AN:
53050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9403
18805
28208
37610
47013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18016
36032
54048
72064
90080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.804
AC:
122429
AN:
152212
Hom.:
49377
Cov.:
34
AF XY:
0.809
AC XY:
60215
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.786
AC:
32639
AN:
41520
American (AMR)
AF:
0.813
AC:
12441
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.800
AC:
2777
AN:
3470
East Asian (EAS)
AF:
0.984
AC:
5095
AN:
5178
South Asian (SAS)
AF:
0.868
AC:
4186
AN:
4822
European-Finnish (FIN)
AF:
0.812
AC:
8610
AN:
10600
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.794
AC:
54018
AN:
68002
Other (OTH)
AF:
0.814
AC:
1721
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1259
2519
3778
5038
6297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
878
1756
2634
3512
4390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.794
Hom.:
150671
Bravo
AF:
0.800
Asia WGS
AF:
0.909
AC:
3159
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.1
DANN
Benign
0.69
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6599222; hg19: chr3-38648062; API